Learn · Research area

Cognitive & Neuro

Neuropeptides and nootropic candidates — Semax, Selank, DSIP and Cerebrolysin — and the neurotrophic, anxiolytic and sleep-regulation research behind them, much of it from the Russian regulatory-peptide school.

Peptide profiles

4 research profiles in Cognitive & Neuro, listed alphabetically.

Compound Research area Overview Read the profile
Cerebrolysin A standardized neurotrophic peptide preparation with one of the deepest clinical-trial records in the field. Cerebrolysin is a standardized mixture of neuropeptides studied across stroke, dementia, and TBI in dozens of registered human trials. Read →
DSIP (Delta Sleep-Inducing Peptide) A naturally occurring nonapeptide tied to deep-sleep regulation and stress signaling. DSIP is an endogenous nonapeptide studied for roles in sleep architecture, stress hormones, and pain — with an early human-research history now being revisited. Read →
Selank A tuftsin-based anxiolytic peptide developed and used clinically in Russia. Selank is a synthetic heptapeptide studied as a non-sedating anxiolytic acting on GABA, serotonin, BDNF, and neuro-immune signaling. Read →
Semax An ACTH-derived neuroprotective peptide already in clinical use in Russia. Semax is a synthetic heptapeptide studied for neurotrophic (BDNF/NGF) and neuroprotective effects, and used clinically in Russian neurology. Read →

← All Learn articles